《Cancer Chemotherapy And Pharmacology》雜志的最新年發文量為120篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在藥學領域的學術影響力。
該刊聚焦于醫學-藥學領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 約2.5月 。
Cancer Chemotherapy And Pharmacology 雜志發文統計
文章名稱引用次數
- Advances in ovarian cancer therapy78
- Positioning of proteasome inhibitors in therapy of solid malignancies24
- Retreatment with pembrolizumab in advanced non-small cell lung cancer patients previously treated with nivolumab: emerging reports of 12 cases22
- A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer20
- A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc((TM))) in patients with locally advanced or metastatic cancer19
- Autophagy modulation: a prudent approach in cancer treatment?18
- Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting16
- A phase II study of modified FOLFIRINOX for chemotherapy-na < ve patients with metastatic pancreatic cancer15
- Cancer immunotherapy: the art of targeting the tumor immune microenvironment15
- The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis15
國家/地區發文量
- USA225
- CHINA MAINLAND162
- Japan152
- England44
- France38
- Italy31
- Netherlands31
- GERMANY (FED REP GER)30
- Switzerland27
- Australia18
